Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Rheumatology International

• Publication date

  2010-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00296-009-1135-9PMID 19779723
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.

  2008cited by this paper
• Increased glomerular matrix metalloproteinase activity in murine lupus nephritis.

  2008cited by this paper
• Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease.

  2006cited by this paper
• NF-kappaB and rheumatic diseases.

  2006cited by this paper
• Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus

  2006cited by this paper
• Role and Function of Matrix Metalloproteinases in the Differentiation and Biological Characterization of Mesenchymal Stem Cells

  2006cited by this paper
• Orphanet Journal of Rare Diseases BioMed Central Review

  2006cited by this paper
• Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease.

  2005cited by this paper
• Excessive matrix metalloproteinase-9 in the plasma of community-acquired pneumonia.

  2005cited by this paper
• Multiple roles of matrix metalloproteinases during apoptosis

  2005cited by this paper
• TIMPs as multifacial proteins.

  2004cited by this paper
• [Relationship of serum levels of HGF and MMP-9 with disease activity of patients with systemic lupus erythematosus].

  2004cited by this paper
• Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.

  2004cited by this paper
• TH1/TH2 cytokine profile, metalloprotease‐9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients

  2003cited by this paper
• Concentrations of circulating matrix metalloproteinase 9 inversely correlate with autoimmune antibodies to double stranded DNA: implications for monitoring disease activity in systemic lupus erythematosus

  2003cited by this paper
• T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients.

  2003cited by this paper
• Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

  2003cited by this paper
• Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases

  2003cited by this paper
• Activity of matrix metalloproteinase‐9 is elevated in sera of patients with systemic lupus erythematosus

  2002cited by this paper
• Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.

  2002cited by this paper
• Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors.

  2002cited by this paper
• Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.

  2001cited by this paper
• Tissue inhibitors of metalloproteinases: evolution, structure and function.

  2000cited by this paper
• Matrix Metalloproteinases in Multiple Myeloma

  2000cited by this paper
• Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers.

  2000cited by this paper
• Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy.

  2000cited by this paper
• Cytokines in the pathogenesis of systemic lupus erythematosus.

  1999cited by this paper
• In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

  1998cited by this paper
• Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells.

  1997cited by this paper
• AMERICAN COLLEGE OF RHEUMATOLOGY REVISED CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC LUPUS ERYTHEMATOSUS

  1997cited by this paper
• Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

  1997cited by this paper
• Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.

  1997cited by this paper
• Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis.

  1997cited by this paper
• Matrix metalloproteinases (MMPs) in renal fibrosis.

  1996cited by this paper
• Systemic lupus erythematosus.

  1996cited by this paper
• Systemic lupus erythematosus.

  1994cited by this paper
• Proteinases and glomerular matrix turnover.

  1992cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper

• Bioinformatics and system biology approach to identify the influences of HIV and LN on the regulation of gene expression

  2025cites this paper
• Harnessing the therapeutic potential of TIMP-1 in autoimmune inflammation: A prospective insight.

  2025cites this paper
• Exploring immunological alterations of B cells in peripheral immunity via single-cell RNA sequencing: insights into primary membranous nephropathy

  2025cites this paper
• Identification of m6A-Related Biomarkers in Systemic Lupus Erythematosus: A Bioinformation-Based Analysis

  2024cites this paper
• Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages

  2024cites this paper
• Correlation between neurofilament, HMGB1, MMP9, ds DNA blood levels and cognitive impairment in patients with neuropsychiatric systemic lupus erythematosus

  2024cites this paper
• Immune landscape and the key role of APOE+ monocytes of lupus nephritis under the single‐cell and spatial transcriptional vista

  2023cites this paper
• Significant hypomethylation of MMP9 gene promoter in patients with systemic lupus erythematosus

  2023cites this paper
• Neutrophils in Inflammatory Diseases: Unraveling the Impact of Their Derived Molecules and Heterogeneity

  2023cites this paper
• Biomonitoring of unmetabolized polycyclic aromatic hydrocarbons (PAHs) in urine of waterpipe/cigarette café workers

  2022cites this paper
• Low-Molecular-Weight Heparin Enhanced Therapeutic Effects of Human Adipose-Derived Stem Cell Administration in a Mouse Model of Lupus Nephritis

  2022cites this paper
• Urinary profile of PAHs and related compounds in women working in beauty salons.

  2022cites this paper
• Urinary level of un-metabolized parabens in women working in beauty salons.

  2021cites this paper
• Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease.

  2021cites this paper
• Role of MMP-2 and its inhibitor TIMP-2 as biomarkers for susceptibility to systemic lupus erythematosus.

  2020cites this paper
• The regulation of trophoblast invasion and decidual reaction by matrix metalloproteinase‐2, metalloproteinase‐7, and metalloproteinase‐9 expressions in the rat endometrium

  2020cites this paper
• MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus

  2019cites this paper
• Matrix metalloproteinases in nephrotic syndrome; a vital but obscure field of research

  2019cites this paper
• Association between PAHs biomarkers and kidney injury biomarkers among kitchen workers with microalbuminuria: A cross-sectional pilot study.

  2018cites this paper
• Adhesion GPCRs in Kidney Development and Disease

  2018cites this paper
• Matrix metalloproteinase-2 and -9 activity levels increase in cutaneous lupus erythematosus lesions and correlate with disease severity

  2018cites this paper
• Gene expression analysis for pneumonia caused by Gram-positive bacterial infection.

  2018cites this paper
• Chronic ethanol ingestion induces glomerular filtration barrier proteins genes expression alteration and increases matrix metalloproteinases activity in the kidney of rats

  2018cites this paper
• Peptidomics of Body Fluids

  2018cites this paper
• The MMP-9/TIMP-1 System is Involved in Fluoride-Induced Reproductive Dysfunctions in Female Mice

  2017cites this paper
• Transplantation of human umbilical cord mesenchymal stem cell relieves the symptoms of lupus nephritis by inhibiting osteopontin expression

  2017cites this paper
• Early Predictors of Acute Kidney Injury: A Narrative Review

  2016cites this paper
• Analysis of immunity index and immunopathogenesis pattern of lupus nephritis patients.

  2015cites this paper
• Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases

  2014cites this paper
• Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus.

  2013cites this paper
• Changes in levels of matrix metalloproteinase-2 and -9, pregnancy-associated plasma protein-A in patients with various nephropathies.

  2013cites this paper
• Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients.

  2013cites this paper
• The beneficial role of vitamin D in systemic lupus erythematosus (SLE)

  2012cites this paper
• TNFα enhances TLR3‐dependent effects on MMP‐9 expression in human mesangial cells

  2012cites this paper
• Imbalances between Matrix Metalloproteinases (MMPs) and Tissue Inhibitor of Metalloproteinases (TIMPs) in Maternal Serum during Preterm Labor

  2012cites this paper
• Matrix metalloproteinases.

  2012cites this paper
• Imbalance of metallaproteinase/tissue inhibitors of metalloproteinase system in renal transplant recipients with chronic allograft injury.

  2011cites this paper
• Cut‐off values for serum matrix metalloproteinase‐9: Is there a threshold to predict renal involvement for Henoch–Schonlein purpura in children?

  2011cites this paper
• GENETIC STUDIES ON FINNISH LUPUS ERYTHEMATOSUS PATIENTS WITH CUTANEOUS MANIFESTATIONS

  2010cites this paper
• MMP-9/TIMP-1 imbalance induced in human dendritic cells by Porphyromonas gingivalis.

  2010cites this paper
• Betulinic acid inhibits high glucose‐induced vascular smooth muscle cells proliferation and migration

  2010cites this paper